AMRS:NSD-Amyris, Inc (USD)

COMMON STOCK | Specialty Chemicals | NSD

Last Closing Price

USD 2.77

Change

+0.06 (+2.21)%

Market Cap

USD 0.55B

Volume

1.40M

Average Target Price

USD 9.00 (+224.91%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Amyris, Inc., a biotechnology company, develops technology that creates microbial strains to produce artemisinic acid, a precursor of artemisinin, an anti-malarial drug. The company's technology platform enables to engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into large volume, high-value ingredients. It applies technology platform to engineer, manufacture, and sell products for the clean health and beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California. Address: 5885 Hollis Street, EmeryVille, CA, United States, 94608

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-09-28 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
BCPC Balchem Corporation

+1.05 (+1.10%)

USD3.09B 37.81 21.22
WDFC WD-40 Company

-1.32 (-0.69%)

USD2.61B 53.10 32.39
IOSP Innospec Inc

+0.75 (+1.19%)

USD1.55B 28.90 12.82
LOOP Loop Industries, Inc

+0.35 (+2.83%)

USD0.52B N/A N/A
GPRE Green Plains Inc

+0.84 (+5.92%)

USD0.51B 40.40 N/A
HWKN Hawkins, Inc

+1.41 (+3.12%)

USD0.48B 15.95 8.47
NTIC Northern Technologies Internat..

-0.01 (-0.12%)

USD0.08B 59.71 10.98
GEVO Gevo, Inc

-0.04 (-4.30%)

USD0.07B 0.30 N/A
HDSN Hudson Technologies, Inc

+0.02 (+1.75%)

USD0.05B 31.20 9.65
GURE Gulf Resources, Inc

-0.19 (-3.80%)

USD0.05B 35.50 3.85

ETFs Containing AMRS

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.36% 38% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.36% 38% F 46% F
Trailing 12 Months  
Capital Gain -41.81% 23% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -41.81% 23% F 14% F
Trailing 5 Years  
Capital Gain -90.81% 18% F 6% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -90.81% 18% F 6% F
Average Annual (5 Year Horizon)  
Capital Gain -15.58% N/A N/A 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -15.58% N/A N/A 13% F
Risk Return Profile  
Volatility (Standard Deviation) 60.62% N/A N/A 17% F
Risk Adjusted Return -25.70% N/A N/A 22% F
Market Capitalization 0.55B 77% C+ 61% D-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio -3.54 77% C+ 71% C-
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital 143.91% 100% A+ 99% A+
Return on Assets -45.49% 15% F 6% F
Debt to Equity Ratio -18.94% 100% A+ 95% A
Technical Ratios  
Short Ratio 9.40 31% F 14% F
Short Percent 22.10% 15% F 9% F
Beta 0.46 92% A- 84% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector